Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2015 Mar;21(3):443. doi: 10.3201/eid2103.ET2103

Etymologia: M. bovis

PMCID: PMC4344296

M. bovis

From the Latin bos (“ox” or “cow”) Mycobacterium bovis is a virulent bacterial species originally isolated from tubercules in cattle. Robert Koch, who discovered the tubercle bacillus in 1882, believed that M. bovis was not a danger to humans. Theobald Smith and others established beyond doubt that, contrary to Koch’s belief, M. bovis could infect humans but was not the usual source of human infection. In 1908, French scientists Albert Calmette and Camille Guérin chose an M. bovis strain for their work on a tuberculosis vaccine. They repeatedly subcultured the isolate on a mixture of glycerol, potato, and bile for 13 years until it was sufficiently attenuated to be used as a vaccine. The bacillus Calmette-Guérin (BCG) vaccine was adopted by the League of Nations as the standard tuberculosis vaccine in 1928 and continues to be used in most developing countries.

Footnotes

Suggested citation for this article: Etymologia: Mycobacterium bovis. Emerg Infect Dis 2015 Mar [date cited]. http://dx.doi.org/10.3201/eid2103.ET2103

Sources

  • 1.LoBue P. Tuberculosis. In: CDC Health Information for International Travel 2014. New York: Oxford University Press; 2014. p. 310–7. [Google Scholar]
  • 2.Schultz MG. Robert Koch [photo quiz]. Emerg Infect Dis. 2011;17:547–9 . 10.3201/eid1703.101881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Smith KC, Orme IM, Starke JR. Tuberculosis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia: Elsevier Saunders; 2013. p. 789–811. [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES